Indivior has announced the departure of several key executives in accordance with the terms of a Merger Agreement. Joseph Ciaffoni has ceased serving as CEO, while Ryan Preblick, Patrick Barry, and Jeffrey Burris have also left their respective positions. The company is currently preparing for the integration of leadership post-merger
Who to call at Indivior Pharmaceuticals, and when
A new leader at Indivior Pharmaceuticals brings new priorities and often new vendors. The first weeks are when they listen.
An alert the day Indivior Pharmaceuticals raises, hires an executive or expands, scored against what you sell
The decision-makers there, with verified emails
Who you already know at Indivior Pharmaceuticals, from your own LinkedIn network
Works inside ChatGPT and Claude. Ask who to call at Indivior Pharmaceuticals. With Fundz connected, it knows.
Trusted byOracleSnowflakeCloudflareLinkedInGoogleSalesforce★★★★★4.8/5 on G2
Company Information
Company
Indivior Pharmaceuticals
Location
Greater London, England, United Kingdom
About
Indivior Pharmaceuticals, Inc. specializes in the treatment of addiction and is engaged in developing medicines to help individuals with substance use disorders. The company focuses on delivering innovative treatments and has a track record of addressing complex medical needs.
AI made execution free. Knowing first is the whole game now.
Fundz sees it the moment Indivior Pharmaceuticals changes its leadership, hires an exec or expands, usually minutes after it happens, and tells you who to reach.